Evaluation of LY573144 (lasmiditan) in a preclinical model of medication overuse headache

por Rau, Jill C, Navratilova, Edita, Oyarzo, Janice, Johnson, Kirk W, Aurora, Sheena K, Schwedt, Todd J, Dodick, David W, Porreca, Frank
Publicado no Cephalalgia (2020)

Heparin Cofactor II in Atherosclerotic Lesions from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Study

por Rau, Jill C., Deans, Carolyn, Hoffman, Maureane R., Thomas, David B., Malcom, Gray T., Zieske, Arthur W., Strong, Jack P., Koch, Gary G., Church, Frank C.
Publicado em 2009